Hemo Organic's Board has approved the financial results for the quarter ending June 30, 2025. The company will hold its 33rd Annual General Meeting (AGM) on September 29, 2025, via video conferencing.

Auditors issued a qualified opinion, citing unconfirmed balances for trade receivables and payables.

The Board also noted a minor penalty of ₹11,800 imposed by the Stock Exchange, which has already been paid.

This update signifies progress on financial reporting and upcoming shareholder engagement, though the auditor's note highlights an area for investor attention regarding balance sheet clarity.